Technical Analysis for THRD - Third Harmonic Bio, Inc.

Grade Last Price % Change Price Change
D 11.62 -6.74% -0.84
THRD closed down 6.74 percent on Wednesday, November 20, 2024, on 89 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Hammer Candlestick Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -6.74%
Bullish Engulfing Bullish -6.74%
Crossed Above 200 DMA Bullish -6.74%
Lower Bollinger Band Walk Weakness -6.74%
Wide Bands Range Expansion -6.74%

   Recent Intraday Alerts

Alert Time
200 DMA Support about 20 hours ago
Lower Bollinger Band Support about 22 hours ago
2x Volume Pace about 22 hours ago
1.5x Volume Pace about 22 hours ago
3x Volume Pace about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Immunoglobulin E Mast Cell Chronic Urticaria

Is THRD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.94
52 Week Low 7.08
Average Volume 241,523
200-Day Moving Average 12.03
50-Day Moving Average 13.30
20-Day Moving Average 13.48
10-Day Moving Average 13.42
Average True Range 1.24
RSI (14) 40.83
ADX 19.47
+DI 15.42
-DI 30.61
Chandelier Exit (Long, 3 ATRs) 11.78
Chandelier Exit (Short, 3 ATRs) 13.82
Upper Bollinger Bands 15.79
Lower Bollinger Band 11.17
Percent B (%b) 0.1
BandWidth 34.24
MACD Line -0.25
MACD Signal Line 0.05
MACD Histogram -0.2945
Fundamentals Value
Market Cap 469.01 Million
Num Shares 40.4 Million
EPS 0.76
Price-to-Earnings (P/E) Ratio 15.29
Price-to-Sales 0.00
Price-to-Book 1.33
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.06
Resistance 3 (R3) 14.93 13.66 14.48
Resistance 2 (R2) 13.66 12.79 13.72 14.29
Resistance 1 (R1) 12.64 12.24 12.01 12.77 14.10
Pivot Point 11.37 11.37 11.05 11.43 11.37
Support 1 (S1) 10.35 10.50 9.72 10.48 9.14
Support 2 (S2) 9.08 9.95 9.14 8.95
Support 3 (S3) 8.06 9.08 8.76
Support 4 (S4) 8.19